대사체학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Metabolomics Market size is expected to reach USD 11.29 Billion in 2034 from USD 3.92 Billion (2025) growing at a CAGR of 12.46% during 2026-2034.

The Global Metabolomics Market is witnessing rapid growth due to rising interest in personalized medicine and advanced disease research. Metabolomics studies small molecules in biological systems, helping scientists understand disease mechanisms and identify biomarkers. Increasing investments in pharmaceutical research and biotechnology are fueling demand for metabolomics technologies.

The market is also driven by technological advancements in mass spectrometry and nuclear magnetic resonance techniques. These tools enable accurate analysis of complex biological samples, supporting drug discovery and clinical diagnostics. Growing focus on early disease detection and precision healthcare is encouraging the use of metabolomics in research laboratories and healthcare institutions.

Looking ahead, integration of artificial intelligence and big data analytics is expected to enhance data interpretation and research outcomes. Expanding applications in nutrition, toxicology, and environmental studies will further broaden market scope. With continuous innovation and rising healthcare investments, the metabolomics market is expected to maintain strong growth momentum in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Metabolomics Instruments
• Metabolomics Bioinformatics Tools and Services

By Application

• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Other Applications

By Indication

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Indications

COMPANIES PROFILED

• Biocrates Life Sciences AG, Shimadzu Corporation, BioRad Laboratories Inc, Waters Corporation, Danaher Corporation, Bruker Corporation, LECO Corporation, Agilent Technologies Inc, Human Metabolome Technologies Inc, Metabolon Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METABOLOMICS MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Metabolomics Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Metabolomics Bioinformatics Tools and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METABOLOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Toxicology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nutrigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METABOLOMICS MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inborn Errors of Metabolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METABOLOMICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Services
  • 7.2.2 By Application
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Services
  • 7.3.2 By Application
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Services
  • 7.4.2 By Application
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Services
  • 7.5.2 By Application
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Services
  • 7.6.2 By Application
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL METABOLOMICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Biocrates Life Sciences AG
  • 9.2.2 Shimadzu Corporation
  • 9.2.3 Bio-Rad Laboratories Inc
  • 9.2.4 Waters Corporation
  • 9.2.5 Danaher Corporation
  • 9.2.6 Bruker Corporation
  • 9.2.7 LECO Corporation
  • 9.2.8 Agilent Technologies Inc
  • 9.2.9 Human Metabolome Technologies Inc
  • 9.2.10 Metabolon Inc